MANS-NRIZ Trial for COVID-19 Treatment : Extension Study

• Status: Recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This search will focus on patients with COVID 19 infection this study is a prospective cohort study based on the analysis of response in comparative panel between two arm Nitazoxanide, Ribavirin and Ivermectin plus Zinc arm and other arm without any intervention as regards the safety and efficacy and cost effective result. Two years duration of the project would be enough to cover the stages of the work as shown below in the time plan. Initial stage of collecting materials and patients' clinical data, each patient will undergoes strict follow up period to reveal the clinical, laboratory and radiological response. The procedures are to be approved by the institutional ethical committee.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mansoura University
• Treatments: Ivermectin; Nitazoxanide; Ribavirin

Criteria

Inclusion Criteria:

• Aged ≥18 years

• Laboratory-confirmed SARS-CoV- 2 infection

• Hospitalized patients

• need reservoir mask for oxygen support

• need HFNC for oxygen support

Exclusion Criteria:

• Mechanical ventilations for oxygen support

• Inability to take oral medications

• Pregnancy or breastfeeding